SETD2 and neoplasm: Strikingly, homozygous deletion of Setd2 accelerated the initiation of KrasG12D lung tumors, increased tumor burden, and significantly reduced mouse survival (Figure 1, A and B, and Supplemental Figure 1, B and C).